Abiopharma

New Form 4 - PFIZER INC Filed: 2025-08-04 AccNo: 0001225208-25-006961 Size: 5 KB

Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants

HLVX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of HilleVax, Inc. Is Fair to Shareholders

New Form 4/A - Nuo Therapeutics, Inc. Filed: 2025-08-04 AccNo: 0001437749-25-024508 Size: 8 KB

Quanterix Announces Cooperation Agreement with Kent Lake Capital

New Form 4 - Nuo Therapeutics, Inc. Filed: 2025-08-04 AccNo: 0001437749-25-024505 Size: 8 KB

Placements::THE PROPOSED PLACEMENT OF UP TO 990,000,000 PLACEMENT SHARES & 660,000,000 WARRANTS IN THE COMPANY

New Form 4 - Nuo Therapeutics, Inc. Filed: 2025-08-04 AccNo: 0001437749-25-024499 Size: 8 KB

New Form 4 - Nuo Therapeutics, Inc. Filed: 2025-08-04 AccNo: 0001437749-25-024497 Size: 9 KB

enVVeno Medical Participates in a New Virtual Investor “What This Means” Segment to Discuss How President Trump’s Recent CVI Diagnosis May Impact the Company

enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to Discuss How President Trumps Recent CVI Diagnosis May Impact the Company

New Form 4 - Nuo Therapeutics, Inc. Filed: 2025-08-04 AccNo: 0001437749-25-024493 Size: 7 KB

CUMBERLAND PHARMACEUTICALS RECEIVES VIZIENT CONTRACT FOR NEWVIBATIV® 4-VIAL STARTER PAK

Placements: THE PROPOSED PLACEMENT OF UP TO 990,000,000 PLACEMENT SHARES & 660,000,000 WARRANTS IN THE COMPANY

Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models